TB-500 + BPC-157 Capsules — 1mg x 30 Capsules | Research Use

Description

An oral-form dual-peptide capsule combining TB-500 and BPC-157, supplied for controlled laboratory research into oral peptide delivery and bioavailability studies.

For laboratory research use only. Not for human or animal consumption.

OVERVIEW

This capsule formulation combines synthetic fragments of thymosin beta-4 (TB-500) and body protection compound (BPC-157) in an oral delivery format. Preclinical research has explored oral peptide stability, absorption modeling, and comparative bioavailability between injectable and oral peptide formats under controlled conditions.

Supplied as capsules for analytical and experimental research applications.

PRODUCT SPECIFICATIONS

Compound: TB-500 + BPC-157 Capsule Blend
Quantity: 30 capsules per bottle
Strength: 1 mg per capsule
Form: Capsule
Purity: ≥98%
Storage: Room temperature, protect from moisture and light

RESEARCH APPLICATIONS

– Oral peptide bioavailability studies
– Delivery format comparison research
– Peptide stability in oral formulations
– Multi-peptide interaction analysis

RESEARCH USE ONLY

This product is intended strictly for laboratory research purposes. Not for human consumption. Not for veterinary use. Not for therapeutic or diagnostic applications. Not intended to treat, cure, or prevent any condition. Use is limited to qualified professionals in controlled laboratory environments.

Certificate of Analysis available upon request.